Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Radiopharmaceutical Added to Stereotactic Radiation Delays Prostate Cancer Progression in Patients with Limited Metastatic Disease

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a radiopharmaceutical drug before targeted radiation, compared with radiation alone.

September 28, 2025


September 28 2025

September 27 2025

September 26 2025

September 25 2025

September 24 2025

September 23 2025

September 22 2025

September 21 2025

September 20 2025

September 19 2025

September 18 2025

September 17 2025

September 16 2025

September 15 2025